I think the strengths of REACH lie in the alternatives assessment and safe substitution in the data-gathering provisions, the fact that there is a reduced emphasis on exposure until much later in the decision-making process relative to the Canadian system.
Again, the whole idea of REACH, how it's organized around registration before access to market, is a way in which you're inherently undertaking a more precautionary type of decision-making than we currently have in CEPA.